Home
>
National Drug Code (NDC)
>
Methotrexate Sodium
Methotrexate Sodium - 0069-0204-10 - (Methotrexate Sodium)
Drug Information of Methotrexate Sodium
| Product NDC: | 0069-0204 |
| Proprietary Name: | Methotrexate Sodium |
| Non Proprietary Name: | Methotrexate Sodium |
| Active Ingredient(s): | 25 mg/mL & nbsp; Methotrexate Sodium |
| Administration Route(s): | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Methotrexate Sodium
| Product NDC: | 0069-0204 |
| Labeler Name: | Pfizer Laboratories Div Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA201529 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120330 |
Package Information of Methotrexate Sodium
| Package NDC: | 0069-0204-10 |
| Package Description: | 10 VIAL in 1 CARTON (0069-0204-10) > 8 mL in 1 VIAL (0069-0204-01) |
NDC Information of Methotrexate Sodium
| NDC Code | 0069-0204-10 |
| Proprietary Name | Methotrexate Sodium |
| Package Description | 10 VIAL in 1 CARTON (0069-0204-10) > 8 mL in 1 VIAL (0069-0204-01) |
| Product NDC | 0069-0204 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Methotrexate Sodium |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRA-ARTERIAL; INTRAMUSCULAR; INTRATHECAL; INTRAVENOUS |
| Start Marketing Date | 20120330 |
| Marketing Category Name | ANDA |
| Labeler Name | Pfizer Laboratories Div Pfizer Inc. |
| Substance Name | METHOTREXATE SODIUM |
| Strength Number | 25 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA] |
